|
O.39ASPIRO phase 1/2 gene therapy trial in X-linked motubular myopathy (XLMTM): update on preliminary safety and efficacy findings |
|
|
|
Title: |
O.39ASPIRO phase 1/2 gene therapy trial in X-linked motubular myopathy (XLMTM): update on preliminary safety and efficacy findings |
Author: |
Dowling, J. Shieh, P. Kuntz, N. Bonnemann, C. Muller-Felber, W. Lawlor, M. Servais, L. Smith, B. Noursalehi, M. Rico, S. Prasad, S. |
Appeared in: |
Neuromuscular disorders |
Paging: |
Volume 29 (2019) nr. S1 pages S207 |
Year: |
2019 |
Contents: |
|
Publisher: |
Published by Elsevier B.V. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|